Celldex Therapeutics reported $54.2M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
Agenus USD 642K 399K Sep/2025
Amgen USD 1.87B 271M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Celldex Therapeutics USD 54.2M 8.94M Jun/2025
Glaxosmithkline GBP 1.88B 1.6B Mar/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pfizer USD 4.09B 498M Jun/2026
Rigel Pharmaceuticals USD 8.03M 5.22M Sep/2024
Roche Holding CHF 7.85B 630M Jun/2026